Investors sold shares of CVS Health (NYSE:CVS) on strength during trading on Monday. $298.69 million flowed into the stock on the tick-up and $345.81 million flowed out of the stock on the tick-down, for a money net flow of $47.12 million out of the stock. Of all equities tracked, CVS Health had the 0th highest net out-flow for the day. CVS Health traded up $2.67 for the day and closed at $66.10
A number of analysts have recently weighed in on the stock. Leerink Swann set a $85.00 target price on shares of CVS Health and gave the stock a “buy” rating in a research report on Tuesday, April 10th. ValuEngine downgraded shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Vetr downgraded shares of CVS Health from a “buy” rating to a “hold” rating and set a $77.11 target price on the stock. in a research report on Thursday, January 4th. Bank of America cut their price objective on shares of CVS Health from $91.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, April 11th. Finally, Morgan Stanley raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and set a $88.00 price objective on the stock in a research report on Friday, January 5th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $86.65.
The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.52 and a current ratio of 1.02. The company has a market capitalization of $67,060.56, a price-to-earnings ratio of 11.37, a P/E/G ratio of 1.10 and a beta of 1.05.
CVS Health (NYSE:CVS) last issued its quarterly earnings data on Thursday, February 8th. The pharmacy operator reported $1.92 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.88 by $0.04. CVS Health had a net margin of 3.58% and a return on equity of 17.21%. The firm had revenue of $48.39 billion for the quarter, compared to analysts’ expectations of $47.54 billion. During the same quarter in the prior year, the business earned $1.71 EPS. The business’s quarterly revenue was up 5.3% on a year-over-year basis. equities analysts expect that CVS Health will post 6.3 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 3rd. Stockholders of record on Monday, April 23rd will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.98%. The ex-dividend date of this dividend is Friday, April 20th. CVS Health’s dividend payout ratio (DPR) is presently 33.90%.
In other news, EVP Helena Foulkes sold 19,965 shares of the stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $71.04, for a total value of $1,418,313.60. Following the transaction, the executive vice president now owns 65,072 shares in the company, valued at approximately $4,622,714.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.61% of the stock is owned by corporate insiders.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Wealthcare Advisory Partners LLC raised its stake in CVS Health by 330.3% during the 3rd quarter. Wealthcare Advisory Partners LLC now owns 1,291 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 991 shares during the period. Fieldpoint Private Securities LLC raised its stake in CVS Health by 333.3% during the 2nd quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,000 shares during the period. Arcadia Investment Management Corp MI raised its stake in CVS Health by 119.6% during the 3rd quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock worth $108,000 after acquiring an additional 726 shares during the period. Wagner Wealth Management LLC bought a new stake in CVS Health during the 4th quarter worth approximately $114,000. Finally, Avestar Capital LLC bought a new stake in CVS Health during the 4th quarter worth approximately $122,000. Institutional investors own 83.97% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This piece of content was posted by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://www.thelincolnianonline.com/2018/04/18/investors-sell-cvs-health-cvs-on-strength-cvs.html.
CVS Health Company Profile
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.